NO930820L - Patogen-spesifikk ctl terapi - Google Patents

Patogen-spesifikk ctl terapi

Info

Publication number
NO930820L
NO930820L NO93930820A NO930820A NO930820L NO 930820 L NO930820 L NO 930820L NO 93930820 A NO93930820 A NO 93930820A NO 930820 A NO930820 A NO 930820A NO 930820 L NO930820 L NO 930820L
Authority
NO
Norway
Prior art keywords
pathogen
specific ctl
ctl therapy
patient
intracellular pathogen
Prior art date
Application number
NO93930820A
Other languages
English (en)
Other versions
NO930820D0 (no
Inventor
Judy Lieberman
Malcolm Gefter
Original Assignee
Immulogic Pharma Corp
New England Medical Center Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US1991/006441 external-priority patent/WO1992004462A1/en
Application filed by Immulogic Pharma Corp, New England Medical Center Inc filed Critical Immulogic Pharma Corp
Publication of NO930820D0 publication Critical patent/NO930820D0/no
Publication of NO930820L publication Critical patent/NO930820L/no

Links

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Fremgangsmåte beskrives for behandling av en pasient infisert med en intracellulær patogen, hvilket omfatter til- førsel til pasienten av en intracellulær patogen-spesifikk, cytotoksisk T lymfocyt-stimulerend-2 antigen, eller et preparat av pasientens lymfocyter anriket for intracellulære patogen- spesif ikke cytotoksiske T lymofocyter.
NO93930820A 1990-09-06 1993-03-05 Patogen-spesifikk ctl terapi NO930820L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US57882890A 1990-09-06 1990-09-06
PCT/US1991/006441 WO1992004462A1 (en) 1990-09-06 1991-09-06 Pathogen-specific ctl therapy

Publications (2)

Publication Number Publication Date
NO930820D0 NO930820D0 (no) 1993-03-05
NO930820L true NO930820L (no) 1993-03-05

Family

ID=26783372

Family Applications (1)

Application Number Title Priority Date Filing Date
NO93930820A NO930820L (no) 1990-09-06 1993-03-05 Patogen-spesifikk ctl terapi

Country Status (1)

Country Link
NO (1) NO930820L (no)

Also Published As

Publication number Publication date
NO930820D0 (no) 1993-03-05

Similar Documents

Publication Publication Date Title
PL309002A1 (en) Therapeutic application of chimeric and radiotracer labelled antibodies, directed against the differentation antigen limited to human lymphocytes b, for treating lymphoma from lymphocytes b
MX9203543A (es) Medicamento.
DK1005870T3 (da) Terapeutisk anvendelse af kimæriske antistoffer mod humant B-lymfocytdifferentieringsantigen til behandling af B-cellelymfom
CA2072573A1 (en) Treatment of human retroviral infections with 2',3'-dideoxyinosine
AU4951196A (en) Vaccines for plague
IL99699A0 (en) Method of treating or preventing type 1 diabetes by oral administration of insulin
DE69017915D1 (de) Zubereitung für den magen.
NO951592L (no) Fremgangsmåte for fremstilling av et transdermalt terapeutisk system
CA2098021A1 (en) Composition Used as a Therapeutic Agent Against Chronic Viral Hepatic Diseases
NO922936D0 (no) Fremstilling av fettsyremedikamenter
DE69110877D1 (de) Idiotypen-impfung gegen b-zell-lymphoma.
AU3204489A (en) A synthetic antigen evoking anti-hiv response
DE3478749D1 (en) Covalently bound heparin - antithrombin-iii complex, method for its preparation and its use for treating thromboembolism
ES2026304A6 (es) Procedimiento de fabricacion de una forma de dosificacion de nicardipina.
SE8204873D0 (sv) Farmaceutiska preparat, innefattande humant insulin och human c-peptid
NO930820L (no) Patogen-spesifikk ctl terapi
KR950702838A (ko) 인터루킨-4(IL-4)를 사용한 사람 면역결핍 바이러스(HIV) 복제의 억제방법(Method for inhibiting HIV replication using IL-4)
AU2229997A (en) Pharmaceutical compositions comprising natural human alpha-interferon
ES2059615T3 (es) Empleo del derivado de tiazol tiprotimoda para la preparacion de un agente para la terapia de infecciones por virus.
ATE111485T1 (de) Peptidbehandlung von hartnäckigen infektionskrankheiten.
AU8501191A (en) Cross-reactive influenza a immunization
Mikhailov et al. The influence of gamma irradiation on hepatitis B virus components and delta antigen.
SU1797350A1 (ru) Способ обнаружения вируса иммунодефицита человека
FR2580176B1 (fr) Vaccin antirabique avirulent
FI883735A7 (fi) Ihmisen immuunikatoviruksen, tyyppi 1, antigeenien valmistus ja käyttö diagnostisena ja terapeuttisena välineenä